Drug Guide
Amoxicillin, Omeprazole Magnesium, Rifabutin
Classification
Therapeutic: Helicobacter pylori infection eradication, Antibiotic, Proton pump inhibitor
Pharmacological: Amoxicillin: Antibiotic (penicillin type), Omeprazole: Proton pump inhibitor, Rifabutin: Antibiotic (ansamycin)
FDA Approved Indications
- Treatment of Helicobacter pylori infection in adults
Mechanism of Action
Amoxicillin inhibits bacterial cell wall synthesis, leading to cell lysis; Omeprazole suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells; Rifabutin inhibits bacterial DNA-dependent RNA polymerase, suppressing RNA synthesis.
Dosage and Administration
Adult: As prescribed, typically multiple doses per day for 10-14 days
Pediatric: Not generally approved for pediatric use outside specific indications; consult specific guidelines
Geriatric: Adjust dose if renal impairment present; monitor closely
Renal Impairment: Dose adjustment may be necessary, especially for rifabutin
Hepatic Impairment: Caution; dose adjustments may be needed, particularly for omeprazole
Pharmacokinetics
Absorption: Amoxicillin: well absorbed; Omeprazole: absorbed with food, peak 1-2 hrs; Rifabutin: well absorbed
Distribution: Amoxicillin: widespread; Omeprazole: binds to plasma proteins; Rifabutin: highly protein-bound
Metabolism: Rifabutin: hepatic; Omeprazole: hepatic via CYP2C19 and CYP3A4; Amoxicillin: minimal hepatic metabolism
Excretion: Renal (amoxicillin, rifabutin), hepatic (omeprazole)
Half Life: Amoxicillin: 1 hr; Omeprazole: 1 hr; Rifabutin: 45 hrs
Contraindications
- Hypersensitivity to penicillins, omeprazole, rifamycins
Precautions
- Liver disease, drug interactions, pregnancy/breastfeeding considerations
Adverse Reactions - Common
- Diarrhea (Common)
- Nausea (Common)
- Headache (Common)
Adverse Reactions - Serious
- Clostridioides difficile-associated diarrhea (Serious)
- Hepatotoxicity (Serious)
- Blood dyscrasias (e.g., leukopenia, thrombocytopenia) (Serious)
Drug-Drug Interactions
- Increases risk of myopathy/rhabdomyolysis with statins when combined with rifabutin
Drug-Food Interactions
- Possible reduced absorption with certain antacids for omeprazole
Drug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for allergic reactions, hepatic function, and improvement in symptoms
Diagnoses:
- Risk for infection, impaired gastrointestinal function
Implementation: Administer with food or as prescribed, monitor for side effects, ensure patient adherence
Evaluation: Assess eradication success via follow-up testing, review lab results
Patient/Family Teaching
- Take medications as directed, complete the full course, report side effects or allergic reactions, avoid alcohol and certain foods as advised
Special Considerations
Black Box Warnings:
- Rifabutin: ocular inflammation, mycobacterial resistance
Genetic Factors: CYP2C19 polymorphisms may affect omeprazole metabolism
Lab Test Interference: Potential false-positive urine glucose tests with omeprazole
Overdose Management
Signs/Symptoms: Gastrointestinal distress, toxicity symptoms depending on component
Treatment: Supportive care, activated charcoal if recent ingestion, specific interventions as per symptoms
Storage and Handling
Storage: Store at room temperature, away from moisture and light
Stability: Refer to specific product stability data